Ohcanbohtosat - C M Buresh

  • Čájehuvvo 1 - 3 / 3
Aiddostahte ozu
  1. 1
    A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice.

    A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice. Dahkki H. Richard Alexander, Gerard M. Doherty, C M Buresh, David Venzon, Jeffrey A. Norton

    Almmustuhtton 1991
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha.

    Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha. Dahkki Gerard M. Doherty, Johan Lange, Howard N. Langstein, H. Richard Alexander, C M Buresh, Jeffrey A. Norton

    Almmustuhtton 1992
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsis.

    Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsis. Dahkki H. Richard Alexander, Brett C. Sheppard, J C Jensen, Howard N. Langstein, C M Buresh, David Venzon, Elijah C. Walker, Douglas L. Fraker, Mark Stovroff, Jeffrey A. Norton

    Almmustuhtton 1991
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: